Among patients who had a second surgery for Crohn’s disease over the past two decades, about 12% underwent a third surgery within 5 years due to disease recurrence. This rate remained stable despite ...
ProKidney Corp., a clinical-stage biotechnology company based in North Carolina, is developing a first-in-class cell therapy ...
NYC practice outlines intake-driven, outcomes-focused approach distinct from spa-based massage NEW YORK, NY, UNITED STATES, ...